GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mydecine Innovations Group Inc (AQSE:MYIG) » Definitions » 3-Year Revenue Growth Rate

Mydecine Innovations Group (AQSE:MYIG) 3-Year Revenue Growth Rate : 0.00% (As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Mydecine Innovations Group 3-Year Revenue Growth Rate?

Mydecine Innovations Group's Revenue per Share for the three months ended in Jun. 2024 was £0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 11 years, the highest 3-Year average Revenue per Share Growth Rate of Mydecine Innovations Group was -18.30% per year. The lowest was -91.90% per year. And the median was -55.10% per year.


Competitive Comparison of Mydecine Innovations Group's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Mydecine Innovations Group's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mydecine Innovations Group's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mydecine Innovations Group's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Mydecine Innovations Group's 3-Year Revenue Growth Rate falls into.



Mydecine Innovations Group 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Mydecine Innovations Group  (AQSE:MYIG) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


Mydecine Innovations Group 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Mydecine Innovations Group's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Mydecine Innovations Group Business Description

Traded in Other Exchanges
Address
1890 – 1075 West Georgia Street, Suite 810, Vancouver, BC, CAN, V6E 3C9
Mydecine Innovations Group Inc is a biopharma and life sciences company engaged in the research, drug development, and clinical trials of psilocybin products.

Mydecine Innovations Group Headlines

No Headlines